The clinical evidence is still pretty early-stage at this point
Last reviewed: June 20, 2026 Last updated: June 20, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
It helps you feel full, satisfied, and more balanced after meals
Both Retatrutide and Tirzepatide are generally safe, but patients should monitor and report any concerns
The practical result is a compound that reduces energy intake through appetite suppression while simultaneously increasing energy expenditure
doi: 10.1016/j.fertnstert.2011.07.928 226 FlorouPAnagnostisPTheocharisPChourdakisMGoulisDG